Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. (Q54638432)
Jump to navigation
Jump to search
scientific article published on 26 October 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. |
scientific article published on 26 October 2010 |
Statements
Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. (English)
Douglas L Fraker
Dana K Furstenau
Nandita Mitra
Fei Wan
Robert Lewis
Michael D Feldman
Marina A Guvakova
26 October 2010
129
2
361-372
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference